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Abstract
Background: The amniotic membrane plays an important role in maintaining a healthy
pregnancy. The main population cells from amniotic membrane include human amnion
epithelial cells (hAECs) which have been shown to possess immunomodulatory
properties.
Objective: The proximity of hAECs with monocyte leads to the generation of
tollerogenic dendritic cells.
Materials and Methods: hAECs were obtained from normal pregnancy. Peripheral
blood monocytes were isolated by anti-CD14 MACSmethod. Co-cultures of monocytes
and hAECs were established in Transwell chambers supplemented with granulocyte-
macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) in the absence
and presence of lipopolysaccharide (LPS) to produce immature and mature DCs,
respectively. Immunophenotyping of the obtained DCs was done through flow
cytometry and the production of cytokines was measured by ELISA. Mixed leukocyte
Reaction (MLR) was also performed for the functional assessment of DCs.
Results: Immunophenotyping of [hAECs - Immature DC (iDC)] and [hAECs - iDC] + LPS
cells revealed that the expression of CD1a, CD80, CD86, CD40, HLA-DR, and CD83
markers showed no significant difference as compared with the control group (iDCs
and mDCs alone). In the [hAECs-iDCs] + LPS cells, the percentage of CD14 cells at
the ratio of 1:2.5 showed significant differences compared to the control group. The
production of IL-10 and IL-12 showed no significant difference in any of the cultures as
compared to the control groups. Also, co-cultured DCs did not inhibit proliferation of
lymphocyte.
Conclusion: Our findings show that factors secreted from cultured hAECs are unable
to generate of tollerogenic dendritic cells. To achieve a better understanding of other
mechanisms more investigations are needed.
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1. Introduction
During pregnancy human embryo is surrounded
by amnion and chorion membranes. The amnion
is in direct contact with the fetus and plays an
important role in the process of normal pregnancy
(1). The properties of the amniotic membrane, such
as its low immunogenicity (2), anti-inflammatory
(3), anti-scarring and wound healing (4) effects,
bring out a wide range of applications for this
membrane in regenerative medicine. Two types of
cells possessing different extents of plasticity have
been isolated from the amniotic membrane and
described by subsequent investigations, including
human amnion epithelial cells (hAECs) and human
amnion mesenchymal stromal cells (hAMSCs)
(5). Feto-maternal immune tolerance plays an
important role in normal pregnancy. This immune
tolerance has motivated many investigators
to study the immune properties of the human
amniotic cells. Previous studies have indicated
that hAECs exhibit low levels of immunogenicity;
consequently, these cells could be transplanted
onto the rabbit cornea without any clinical side
effects or tissue rejection (6). The lack of human
leukocyte antigen (HLA)-II and co-stimulatory
molecules in the presence or absence of interferon
gamma (IFN-γ), low expression of HLA-I (5, 7), and
constitutive expression of HLA-G (8) by hAECs
may be partly responsible. Another important
feature of hAECs is their immunomodulatory
properties. hAECs produce migration inhibitory
factors and inhibit the migration of macrophages
(2).
It has been indicated that prostaglandin E2
(PGE2) and transforming growth factor beta (TGF-
β1) are the most powerful immunomodulatory
factors produced by hAECs, which have been
also shown to suppress T cell proliferation (9).
Besides, hAECs inhibit proliferation of peripheral
blood mononuclear cells (PBMCs) previously
activated by mitogens (7, 10). Moreover, the
secretary factors from hAECs have been shown
to induce apoptosis of activated T cells (2).
Due to the immunomodulatory properties of
hAECs, these cells are expected to be potentially
used as a therapy to modulate pathogenic
immune responses. Recently, investigations
indicated that the hAECs can be used for
the treatment of inflammation-mediated spinal
cord injury (11), hepatic fibrosis (12), multiple
sclerosis (9), and inflammatory pulmonary fibrosis
(13).
The basic mechanisms of the
immunosuppressive properties of hAECs are
not yet clear. Dendritic cells (DCs) Known as
the most potent professional antigen-presenting
cells for naive T cells and are important role
in initiating and regulating immune responses
(14). The maturation state of DCs in combination
with environmental and endogenous factors
determine stimulatory or tolerogenic properties
of lymphocytes (15). The absence of costimulatory
molecules and major histocompatibility complex
class II (MHCII) on tolerogenic DCs lead
to induce T cell anergy, preventing T cell
activation.
Many protocols have been established
to generate tolerogenic DCs using numerous
agents, including glucocorticoids such as
dexamethasone, mycophenolic acid, vitamin
D3, retinoic acid, and the combination of
dexamethasone and vitamin D3, all of which
prevent the maturation of the dendritic cell.
Therefore, ex-vivo-generated tolerogenic DCs
as therapeutic vaccines are suitable candidates
to “re-establish antigen-specific tolerance in
autoimmune disorders” (16). Recent investigations
indicate that mesenchymal stem cells (MSCs)
obtained from various tissues can affect the
maturation of DCs and inhibit DC differentiation
of peripheral blood monocytes (16-19). Since
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the findings on the immunomodulatory
properties of hAECs are in accordance with
those explained for MSCs obtained from
the amnion membrane, bone marrow (20),
cord blood (20) and adipose tissue (21), so
far.
In the current research, we studied whether
secreted factor from hAECS can also inhibit
monocytes‘ differentiation towards DCs.
Furthermore, we investigated the production
of interleukin (IL)-10 and IL-12 by DCs and the
ability of these DCs to stimulate T cell proliferation.
2. Materials and Methods
2.1. Reagents and antibodies
Reagents used in the cell culture and Ficoll-
Paque 1077 were obtained from Gibco (UK).
Fluorescein isothiocyanate (FITC)-conjugated
monoclonal antibodies (mAb) against human
cytokeratin, CD34, CD9, CD38, HLA-G, HLA-
DR and phycoerythrin (PE)-conjugated mAbs
against CD133, CD29, CD44, SSEA-4, CD73,
CD10, HLA-I, and corresponding isotype controls
were all purchased from BD biosciences (USA).
PE-conjugated anti-CD105 and unconjugated
anti-STRO-1 mAb were from R&D System (USA).
Polyclonal rabbit anti-human OCT-4 and FITC-
conjugated goat anti-rabbit antibodies were
purchased from Abcam (USA) and Sigma
(USA), respectively. FITC-conjugated sheep anti-
mouse Ig was obtained from Avicenna Research
Institute (Iran). Anti-CD14-coated microbeads and
magnetic-activated cell sorting (MACS) separation
columns were purchased from Miltenyi Biotech
(Germany). PE-conjugated CD14 antibody was
obtained from BD (USA). FITC-conjugated anti-
CD80, HLA-DR, PE-conjugated anti-CD14, CD83,
CD86, CD1a, and PECY5-conjugated anti CD40
and corresponding isotype controls were all
purchased from BD (USA). Recombinant IL-4
and granulocyte-macrophage colony-stimulating
factor (GM-CSF) were obtained from R&D (USA).
Lipopolysaccharide (LPS) was purchased from
Sigma (USA). IL-10 and IL-12 ELISA kits were
obtained from R&D (USA). [3H] thymidine was
purchased from Amersham (USA). Glass-fiber
filter was obtained from Titertek (USA). Human
Regulatory T Cell Staining Kit was obtained from
eBiosciences (USA).
The sampling of human Buffy coats from
healthy donors and early term placental units of
healthy mothers due to the inclusion criteria was
randomized selection.
The sampling of human Buffy coats from
healthy donors and early term placental units of
healthy mothers due to the inclusion criteria was
randomized selection.
2.2. Isolation of human amniotic
epithelial cells
Human placentas were obtained from
uncomplicated term pregnancies delivered by
elective Cesarean section from healthy women
aged 20 to 35 yr. Amniotic epithelial cells were
isolated and characterized using flow cytometry
in accordance with the protocols described
by Tabatabaei and colleagues (22). In brief,
amniotic membranes were peeled free from
the underlying chorion and washed several
times. The membranes were divided into four
parts and were placed in cell culture flask of
75 cm2. Then, 15-20 mL of buffer containing
0.05% trypsin-EDTA and 20 µg/ml DNase was
added to each flask to perform four successive
digestion steps. The viability of harvested cells
was examined by trypan blue exclusion test.
Single cell suspensions obtained from steps 2-4
were pooled and analyzed by flow cytometry
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for the expression of cytokeratin, CD9, CD10,
CD29, CD73, CD34, CD38, CD44, CD105, CD133,
HLA-I, HLA DR, HLA-G, SSEA-4, STRO-1, and
OCT-4.
2.3. Cultivation of hAECs
Harvested hAECs from each membrane were
cultured in complete tissue culturemediumRoswell
park memorial institute (RPMI 1640) + FBS10% +
Penicillin/Streptomycin in 25 cm2 tissue culture
flasks. Two days after that, semi-adherent cells
were removed to be used for co-culture.
2.4. Isolation and purification of
monocytes from human peripheral
blood
Blood samples were obtained from healthy
donors admitted to the Blood Transfusion
Organization, Tehran, Iran according to the
policy approved by the Ethical Committee.
PBMCs were isolated by Ficoll-Paque 1077
density gradient centrifugation. Peripheral blood
monocytes were isolated by anti-CD14-coated
microbeads and MACS separation columns
through positive selection according to the
manufacturer’s protocol. Monocytes were stained
with PE-conjugated anti-CD14 antibody. The
flow cytometry analysis confirmed a purity of >
98%.
2.5. Induction of monocyte-derived
DCs
Based on previous studies, peripheral blood
monocytes were differentiated to iDCs by
the use of IL-4 and GM-CSF. mDCs were
developed by adding LPS in iDCs culture. In
order to developing iDCs, The monocytes (1 ×
106/ml) were cultured in 1 ml RPMI complete
medium (supplemented with 10% fetal bovine
serum (FBS), recombinant GM-CSF (50 ng/ml)
and IL-4 (100 ng/ml)) and seeded in 24-well
culture plate at 1 ml/well and followed by
incubation in 37°C for 3-5 days. Then iDCs
were stimulated by adding 100 ng/ml LPS and
incubated for 2 more days in order to developing
mDCs.
2.6. Co-culture of monocyte-derived
DCs and hAECs
Co-cultures of monocytes and hAECs (at
passages 0) were established in Transwell 0.4
µm pore size membrane chambers obtained
from SPL (Korea). Monocytes were co-cultured
with hAECs at monocytes: hAEC ratios of
1:1, 1:2.5, and 1:10. For the production of
immature DCs (iDCs), 1.5 × 106 monocytes
were cultured in the inferior chambers of the
Transwell plates and hAEC were cultured in
the insert chambers at a total volume of 2.5
mL of complete medium (RPMI + 10% FBS, 0.2
M L-glutamine, non-essential amino acids, 1%
Sodium pyruvate) with GM-CSF (100 ng/mL)
and IL-4 (50 ng/mL) for five days. The cells
from this co-culture were named [hAECs-iDCs].
For the production of mature DCs (mDCs)
from the co-cultures, the same approach was
followed with the only difference that on
the fifth day, the supernatant (1 mL) of the
monocytes were collected and replaced with
fresh medium containing LPS (50 ng/mL). The
supernatant (1 mL) of the hAECs were collected
as well and replaced with fresh medium and
the cells were cultured for two more days.
The cells from these co-cultures were named
[hAECs-iDCs] + LPS. In both co-culture models,
monocytes alone were used as the control
groups.
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2.7. Flow cytometry analysis
For the immunophenotyping of the DCs
obtained from our co-cultures, anti-CD80,
HLA-DR (FITC-conjugated), anti-CD83, CD14,
CD86 and CD1a (PE-conjugated), anti-CD40
(PECY5-conjugated) antibodies were used. In
all the tests, the isotype-matched antibodies
were used as negative controls. Briefly, the
cell suspensions were incubated for 30 min
at 4°C in a staining solution (PBS + 2% FBS +
antibody). After the incubation, the cells were
washed and analyzed by flow cytometry (Partec,
Germany).
2.8. Cytokine assays
To evaluate the production of IL-12 and IL-10,
co-culture supernatants were collected on day
5 for iDC and day 7 for mDC and stored at -
80°C until being tested. [hAECs-iDCs] and [hAECs-
iDCs] + LPS co-culture supernatants were used for
the test groups and iDC, mDC, and hAECs alone
were used as the control groups. Measurement
of Cytokineswere assayed with an ELISA Kit
according to the manufacturer’s instructions. “The
optical density of the wells plate were read
using Anthos ELISA reader at 570 and 450 nm
(as reference wavelength) .The minimal detection
limits for IL-10 and IL-12 was 31.25 pg/mL”.
2.9. Proliferation assay
2.9.1. Preparation of Peripheral blood
lymphocytes (PBLs) as responder cells in
the mixed leukocyte reaction (MLR)
In order to prepare PBLs, appropriate blood
volumes were taken from healthy donors and
PBMCs were isolated using standard procedures
with Ficoll-isopaque and Percoll density gradient
centrifugation. Next, the harvested cells were
cultured in complete tissue culture medium in T25
(SPL, Korea) tissue culture flasks for 2 hr in a 37°C
incubator supplemented with 5% CO2. Then, the
non-adherent cells, that is, the PBLs were slowly
collected and after washing at 200 g for 5 min in
fresh medium, the PBLs were used as responders
for the allogeneic mixed lymphocyte reaction (allo-
MLR).
2.10. Mixed leukocyte reaction
MLR was performed to assess the function
of cells within the [hACEs-iDCs] + LPS group.
Briefly, [hACEs-iDCs] + LPS cells were cultured
with PBL at the three effector: target ratios of
1:1, 1:2.5, and 1:10 for five days. All cultures
were carried out in triplicate in round-bottom 96-
well tissue culture plates, at a final volume of
200 µL of RPMI complete medium. Co-culture
of [hAECs-iDCs] + LPS cells with PBLs were
deemed as the test groups and the co-culture of
mDC with PBLs were deemed as our controls.
[hAECs - iDCs] + LPS cells alone and PBLs alone
were used as negative controls, and the co-
cultures of Phytohemagglutinin (PHA) with PBLs
were used as positive controls. T-cell proliferation
was assessed after five days by adding [3H]
thymidine (1 µCi/well) for 16-18 hr. Cells were then
harvested with a cell harvester on the glass-
fiber filter. Then the filters were placed onto the
scintillation vials and the scintillation liquid was
added, and finally, thymidine incorporation was
measured using a β-Counter (LKB Wallac, 1410,
USA).
2.11. Regulatory T cell assay
In order to evaluate the ability of [hAECs-
iDCs] + LPS cells to generate T-regs, [hAECs-
iDCs] + LPS and mDC cells were co-cultured
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with PBLs for five days at a ratio of 1:1. PBLs
alone were used as negative controls. Cells
were stained with the Human Regulatory T Cell
Staining Kit and anti-CD4, CD25, and Foxp3
antibodies and analyzed by flow cytometry (Partec,
Germany).
2.12. Ethical consideration
This study was approved by the ethical
committee of Shahid Beheshti University of
Medical Sciences, Tehran, Iran (code: 92556) and
all participants signed a written consent form
before enrolment in the study.
2.13. Statistical analysis
The statistical analysis was performed using
GraphPad Prism 5.0 (GraphPad Software, Inc.,
La Jolla, CA, http://www.graphpad.com) software.
One-way ANOVA was used to compare the means
of normally distributed data, and nonparametric
Kruskal-Wallis, Mann-Whitney, and Dunnett tests
were used for the not normally distributed data.
The results were presented as mean ± SD; p
< 0.05 was considered statistically significant.
The results are representative of four individual
experiments.
3. Results
3.1. Isolation and immunophenotyping
of hAECs
About 70-120 × 106 per/membrane hAECs were
isolated from each placenta unit with high purity
as determine by the evaluation of cytokeratin
expression (≥ 90%). Trypan blue dye exclusion test
disclose a viability of > 95%. These cells appeared
as flat round cells (Figure 1A). Immunophenotyping
of hAECs was evaluated by flow cytometry.
Accordingly, hAECs were positive for cytokeratin,
CD9, CD10, CD29, CD73, CD105, HLA-I, HLA-G,
STRO-1, SSEA-4, and OCT-4 while negative for
HLA-II, CD34, CD38, CD44, and CD133 (Figure
1B).
3.2. Immunophenotyping of monocyte
and monocyte-derived cells in the
absence of hAEC
A analysis of CD14 expression levels by flow
cytometry showed that monocytes were isolated
with a purity of 98 ± 0.9%. As expected, purified
monocytes were positive for the CD86 and
HLA-DR and negative for CD80, CD83, CD40,
and CD1a. Immunophenotyping of iDC on day
5 showed that during the process of monocyte
differentiation into iDC, CD14 strongly reduced
and CD1 (specific marker of monocyte-derived DC)
significantly increased as a result of differentiation.
Also, these cells were positive for CD80, CD86,
and CD40. Immunophenotyping of mDC on
day 7 showed that during the process of iDC
differentiation intomDC, CD1a and CD83 increased
significantly. These mDC cells were negative for
CD14 and positive for CD83, CD80, CD86, CD40,
and HLA-DR. These results demonstrate the
successful differentiation of iDC to mDC (Figure
2).
3.3. Immunophenotyping of monocyte
derived iDC cells in the presence of
hAEC
Monocytes co-cultured with hAEC for five
days in the presence of IL-4 and GM-CSF were
stimulated to differentiate into iDC cells. The
cells from this co-culture were named [hAECs-
iDCs]. Immunophenotyping of [hAECs-iDCs] cells
revealed that the percentage of CD1a (p = 0.59)
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and CD14 (P-value = 0.27) cells in all three
ratios of 1:1, 1:2.5, and 1:10 showed no significant
difference as compared with the control group
(Figure 3A). The expression of CD80 (p = 0.82),
CD86 (p = 0.82), CD40 (p = 0.76), HLA-DR (p =
0.87), and CD83 (p = 0.72) markers also showed
no significant difference with the control group
(Figure 3B). The Kruskal-Wallis test was used
to analyze groups. P < 0.05 was considered
significant.
3.4. Immunophenotyping of monocyte
derived mDC cells in the presence of
hAEC
With the addition of LPS to hAECs-iDCs cells
and incubation for two more days, cells were
stimulated to differentiate into mDC. The cells
from this co-culture were characterized as [hAECs-
iDCs] + LPS cells. Immunophenotyping of [hAECs-
iDCs] + LPS cells revealed that the percentage
of CD1a cells in all three ratios of 1:1, 1:2.5,
and 1:10 showed no significant difference as
compared with the control group (p = 0.2).
The Percentage of CD14 cells in the ratio 1:2.5
showed significant differences compared with
the control group (p = 0.02) (Figure 4A). The
expression of CD80 (p = 0.83), CD86 (p =
0.97), CD40 (p = 0.47), HLA-DR (p = 0.10),
and CD83 (p = 0.93) markers also showed
no significant difference with the control group
(Figure 4B). The Kruskal-Wallis test was used to
analyze groups. P-value < 0/05 was considered
significant.
3.5. Effect of hAECs on DC cytokine
production
Since the cytokine microenvironment has a
very important role in the maturation, recruitment,
and functioning of DCs, we next evaluated
IL-10 and IL-12 in supernatant of co-cultures
in all three ratios of 1:1, 1:2.5, and 1:10. As
shown in Figure 5, in production of IL-10 and
IL-12 there is no significant difference in any
of the cultures as compared to the control
groups. We used one-way analysis of variance
(ANOVA) test to analyze groups. IL-12 was not
detected in the supernatant of iDC cells (data not
shown).
3.6. hAECs don’t affect the ability of
DC to induce PBL proliferation
To evaluate the functional ability of [hAECs-
iDCs] + LPS cells to induce the PBL cells
proliferation, MLR test was used. According to
the results, there was no significant difference
between [hAECs-iDCs] + LPS and mDC cells in
stimulation of PBLs cells proliferation. Average
CPM for [hAECs-iDCs] + LPS cells in the three
ratios of 1:1, 1:2.5, and 1:10 was 23630 ±
644/8, 23608 ± 846/4, and 25674 ± 2560,
respectively, and for mDC 23237 ± 1047 (Figure
6). We used one-way ANOVA test to analyze
groups.
3.7. hAECs don’t affect the ability of DC
to induce Treg expansion
In order to assess the [hAECs-iDCs]+ LPS cells’
ability to induce T-reg cells, [hAECs-iDCs]+ LPS and
mDC cells were co-cultured with PBL cells for five
days at the ratio 1:1. PBL cells alone were used
as negative controls. According to the results, in
MLR reaction, the percentage of Treg cells did not
show significant difference between [hAECs-iDCs]
+ LPS (and mDC cells (Figure 7) (P-value = 0.99).
One-way analysis Mann-Whitney test was used to
analyze groups. P-value < 0/05 was considered
significant.
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Figure 1. (A) Morphology of freshly isolated human amniotic epithelial cells (hAECs)(×100). (B) Immunophenotype of isolated
hAECs Open histograms display cells stained with monoclonal antibodies and filled histograms display cells stained with isotype-
matched control antibodies. The percentage of positive cells is shown in each plot. The results are representation of six separate
experiments.
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Figure 2. Immunophenotyping of monocyte and monocyte-derived cells in the absence of Human amniotic epithelial cells. (A)
Immunophenotype profile of monocytes (Day 0), immature dendritic cells (day 5) and mature dendritic cells (day 7). Monocytes
were isolated by magnetic activated cell sorting and were differentiated to immature dendritic cells s by the use of IL-4 and GM-
CSF for five days. Then, immature dendritic cells were stimulated by adding 100 ng/ml LPS and incubated for two more days
(day 7). Immunophenotype of cells were measured using flow cytometry. Open histograms display cells stained with monoclonal
antibodies and filled histograms display cells stainedwith isotype-matched control antibodies. experiments. (B) The figure displays
the percentages of cells staining positive for each marker; * indicates statistically significant differences of cells. iDC: immature
dendritic cells, mDC: mature dendritic cells.
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Figure 3. Immunophenotyping of monocyte-derived immature dendritic cells in the presence and absence of Human amniotic
epithelial cells. Monocytes cultured with GM-CSF plus IL-4 for three-five days in the presence of Human amniotic epithelial cells in
Transwell. Monocyte cells were cultured at ratios 1:1, 1:2.5, and 1:10 (monocytes: hAECs). [hAECs-iDCs] were analyzed for markers
shown in the figure using flow cytometry. (A) The percentages of cells staining positive for CD1a and CD14. (B) The mean of Mean
Ratio Fluorescence Intensity for each marker. Data are expressed as mean ± SD of four separate experiments. [hAECs-iDCs]:
monocyte derived immature dendritic cells in the presence of Human amniotic epithelial cells. MRFI: Mean Ratio Fluorescence
Intensity. iDC: monocyte derived immature dendritic cells in the absence of Human amniotic epithelial cells.
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Figure 4. Immunophenotyping of monocyte-derived mature dendritic cells in the presence and absence of Human amniotic
epithelial cells. Monocytes were culturedwith GM-CSF plus IL-4 for three-five days in the presence of human amniotic membrane in
Transwell. Then, immature dendritic cells were stimulated by adding 100 ng/ml LPS and incubated for two more days (day 7). The
cells from this co-culture were named [hAECs-iDCs] + LPS. Monocyte cells were cultured at ratios 1:1, 1:2.5, and 1:10 (monocytes:
human amniotic membrane). [hAECs-iDCs] + LPS were analyzed for markers shown in the figure using flow cytometry. (A) The
percentages of cells staining positive for CD1a and CD14. (B) The mean of Mean Ratio Fluorescence Intensity for each marker.
Data are expressed as mean ± SD of four separate experiments. The Kruskal-Wallis test was used to analyze. MRFI: Mean Ratio
Fluorescence Intensity. mDC: monocyte derived immature dendritic cells in the absence of Human amniotic epithelial cells and
then maturated with LPS for two days.
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Figure 5. The cytokines of IL-10 and IL-12 were evaluated from supernatants of monocyte cultures differentiated toward dendritic
cells in the absence (mature dendritic cells and immature dendritic cells) or presence ([hAECs-iDCs] and [hAECs-iDCs] + LPS of
human amniotic epithelial cells in Transwell conditions. IL-12 was not detected in the supernatant of immature dendritic cells (data
not shown). The results are the mean ± SD of four individual supernatants for each cell population. nd, not detected; hAEC, human
amniotic epithelial cells; mDC, mature dendritic cells; iDC, immature dendritic cells; [hAECs-iDCs]: monocyte-derived iDC cells in
the presence of hAEC; [hAECs-iDCs] + LPS, monocyte-derived iDC cells in the presence of hAEC and then maturated with LPS for
two days.
Figure 6. Effect of hAECs-treated monocyte-derived mDCs on PBL cells proliferation. Mature dendritic cells (control group) and
[hAECs-iDCs] + LPS were collected after culture and used as stimulators to induce proliferation of peripheral blood lymphocytes
cells (responders). Co-culture of [hAECs-iDCs] + LPS cells with peripheral blood lymphocytes cells were used as test, co-culture of
mDC with peripheral blood lymphocytes cells were used as control, [hAECs-iDCs] + LPS cells and peripheral blood lymphocytes
cells alone were used as negative controls, co-culture of Phytohemagglutinin with peripheral blood lymphocytes cells was used
as positive control. T cell proliferation was measured by [3H] thymidine incorporation assessment after five days of culture and
expressed as counts per minute (cpm). Average cpm for [hAECs-iDCs] + LPS cells in the three ratios of 1:1, 1:2.5, and 1:10 was 23630
± 644/8, 23608 ± 846/4, and 25674 ± 2560, respectively, and for mature dendritic cells 23237 ± 1047. The results shown are the
mean ± SD of four individual experiments. hAEC, human amniotic epithelial cells; mDC, mature dendritic cells; PBL, Peripheral
blood lymphocytes; PHA, Phytohemagglutinin; [hAECs-iDCs] + LPS, monocyte derived immature dendritic cells in the presence
of hAEC and then maturated with LPS for two days.
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Figure 7. Regulatory T cells assay. In order to evaluate the [hAECs-iDCs] + LPS cells’ ability to generate T-reg cells, [hAECs-iDCs]
+ LPS and mature dendritic cells were co-cultured with peripheral blood lymphocytes cells for five days at the ratio 1:1. Peripheral
blood lymphocytes cells alone were used as negative controls. Cells were stained by Human Regulatory T Cell Staining Kit and
anti-CD4, CD25, and Foxp3 antibodies and analyzed by flow cytometry. (A) indicates the flow cytometry gating strategy used to
quantitate CD4 + CD25 + FoxP3 + Treg cells. As shown in (B), in the percentage of Treg cells there was no significant difference
between [hAECs-iDCs] + LPS and mature dendritic cells. mDC, mature dendritic cells; PBL, Peripheral blood lymphocytes; [hAECs-
iDCs] + LPS, monocyte-derived iDC cells in the presence of hAEC and then maturated with LPS for two days.
4. Discussion
Based on the results, although hAECs could
not significantly affect the differentiation of
monocytes into DCs in our experimental settings,
but they were able to partially decrease the
expression of CD1a and CD14 at co-culture
ratios of 1:1 and 1:2.5, respectively. There
are many conflicting studies regarding the
immunomodulatory properties of hAECs’ secreted
factors.
Our team has successfully isolated and
characterized hAECs in a previous study
(22). Based on the findings, harvested hAECs
possessed many of the MSC properties (22).
Keeping in mind the known immunosuppressive
function of these cells during pregnancy,
we have evaluated in the present study the
immunomodulatory properties of soluble factors
secreted from hAECs on DC differentiation
and cytokine production taking advantage of a
Transwell co-culture system.
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DCs, as the central regulators of the immune
system, are among the most important cells
affected by such an environment, which can largely
influence the fate of the pregnancy (14). It is
also known that the amniotic membrane is a
key role player in the maintenance of human
pregnancy, which consists of two major cell
types including hAMCs and hAECs. In this regard,
hAMCs have been shown by several studies to
exert immunomodulatory effects on DC maturation
in both indirect (Transwell) and direct contact
co-culture systems (17, 23). Acknowledging the
findings of previous studies indicating that hAECs
share some of the immunomodulatory properties
with hAMCs (2, 10), we made an effort in the
present study to check whether the hAECs isolated
from human amniotic membrane during Cesarean
sections of women with term pregnancies can
also affect the differentiation of monocytes toward
DCs.
Some studies have demonstrated that B and
T cells proliferation as well as the chemotactic
activities of neutrophils and macrophages as
evidenced by the production of the macrophage
inflammatory protein 2 (MIP)-2 can be inhibited
by the supernatant from hAECs cultures (2).
While other studies have shown that direct cell-
to-cell contact is necessary for the AECs to
exert their immunomodulatory effects (10, 17).
In agreement with these findings, Magatti and
colleagues showed that the effect of hAECs on
monocytes differentiation toward DCs and the
ability of these differentiated DCs to induce T
cell proliferation were more pronounced in the
cell-to-cell contact co-culture system compared
to the indirect Transwell system (17). These
findings all together show that although the
soluble factors secreted from hAECs possessed
immunomodulatory properties and could inhibit
the proliferation of immune cells in many studies,
these soluble factors alone, however, were unable
both effectively influence the differentiation of
monocytes toward effector DCs and to convert
DCs to tolerogenic phenotypes. In contrast,
signals received from hAECs during cell-to-cell
crosstalk could effectively promote differentiation
of monocytes toward tolerogenic DCs. The
mechanisms responsible for these events
are still not completely understood. Studying
the ability of cell-to-cell contact alone in the
absence of hAECs-secreted factors to induce
tolerogenic DCs remain unanswered because
of the limitations in the design of such an
experimental model.
In another study, Magatti and colleagues
observed that in contrast to hAMCs, the inhibitory
capacity of hAECs correlated inversely with their
numbers in the culture. These findings reveal
that the determination of an optimal dose is
an essential prerequisite for the clinical and
experimental application of hAECs. Many studies
have indicated that increasing the passage number
of hAECs leads to the acquisition of mesenchymal
markers (such as CD105, CD13, CD44, and CD90)
as well as epithelial-mesenchymal transition (24-
26). Such a phonotypic shift led to a reduced
immunomodulatory capacity of hAECs in these
studies (17). Considering these important findings,
we used hAECs at passage 0 in our experiments
to avoid such a deteriorating phenotypic change.
It is well-known that the cytokine profile, the
ability to stimulate T cells, and the functional
capacity of DCs are the three important arms
implicated in promoting the immune response (27).
Therefore, in the present work, we evaluated two
cytokines, that is, IL-10 and IL-12 in supernatant
of the co-cultures. Neither the production of
IL-10 nor of IL-12 differed significantly between
the test groups and the control group, which is
consistent with the findings of the study by Magatti
and colleagues in which the inhibitory effects
of hAECs on the production of inflammatory
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cytokines were only seen in the direct cell-to-
cell contact co-culture system (17). According to
another study by Chang and colleagues (28), the
mDC type 1, which is the same DC produced in
our study, produces very small amounts of IL10;
which is in parallel with our findings. Our findings
on the functional ability of generated DC (in the
presence of hAECs) to induce PBL proliferation
and Treg expansion in MLR reaction indicated
that PBLs co-cultured with hAECs. Moreover,
we observed that hAECs don’t affect cytokine
production and Treg expansion of DCs. In line with
this, Magatti and colleagues indicated that only
DCs generated in the direct cell-to-cell system
but not those generated in the Transwell system
had a significantly reduced ability to stimulate
T-cell proliferation. Moreover, the cytokine profile
of hAEC-treated DCs was more dominant in the
direct cell-to-cell contact condition, compared to
the Transwell system (17). All in all, these findings
along with the findings of previous studies are
in agreement with our results emphasizing the
inability of hAECs soluble factors to influence
monocyte differentiation into DCs as well as the
necessity of a direct cell-to-cell contact for the
hAECs-driven immunomodulatory effects to take
place.
5. Conclusion
Our findings show that the factor secreted
from freshly isolated hAEC at the primary
passage (passage 0) is unable to inhibit the
generation of mDCs. Therefore, perhaps the
immunomodulatory effects of hAECs in diseases
of inflammatory or autoimmune pathogenesis
is mediated through a direct cell-to-cell
contact mechanism. Indeed, further research
with proper experimental designs will aid in
uncovering the ambiguous aspects of these
findings.
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